(NASDAQ: XRAY) Dentsply Sirona's forecast annual revenue growth rate of 0.94% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.59%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.32%.
Dentsply Sirona's revenue in 2026 is $3,575,000,000.On average, 20 Wall Street analysts forecast XRAY's revenue for 2026 to be $710,182,781,952, with the lowest XRAY revenue forecast at $676,100,349,336, and the highest XRAY revenue forecast at $744,265,214,568. On average, 20 Wall Street analysts forecast XRAY's revenue for 2027 to be $713,353,240,800, with the lowest XRAY revenue forecast at $665,400,050,724, and the highest XRAY revenue forecast at $757,145,203,638.
In 2028, XRAY is forecast to generate $731,187,071,820 in revenue, with the lowest revenue forecast at $680,063,422,896 and the highest revenue forecast at $779,140,261,896.